Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" |Disease | ! rowspan="3" |Disease | ||
! colspan=" | ! colspan="10" |Symptoms | ||
! rowspan="3" |History | ! rowspan="3" |History | ||
! rowspan="3" |Physical | ! rowspan="3" |Physical | ||
Line 13: | Line 13: | ||
|- | |- | ||
! rowspan="2" |Age of onset | ! rowspan="2" |Age of onset | ||
! rowspan="2" |Site of muscle weakness | |||
! colspan="2" |Muscle weakness | ! colspan="2" |Muscle weakness | ||
! rowspan="2" |Fever | ! rowspan="2" |Fever | ||
Line 28: | Line 29: | ||
!DIstal | !DIstal | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Medications | ||
|- | |- | ||
|Corticosteroids | |Corticosteroids | ||
|Variable | |Variable | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 61: | Line 63: | ||
|Statins | |Statins | ||
|60+ | |60+ | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 87: | Line 90: | ||
|Alcohol | |Alcohol | ||
|Variable | |Variable | ||
| | |||
| '''+''' | | '''+''' | ||
| | | | ||
Line 106: | Line 110: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Endocrine | ||
|- | |- | ||
|Cushing's disease | |Cushing's disease | ||
|25 -45 | |25 -45 | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 146: | Line 151: | ||
|- | |- | ||
|Adrenal insufficiency | |Adrenal insufficiency | ||
| | |||
| | | | ||
| | | | ||
Line 164: | Line 170: | ||
|- | |- | ||
|Secondary hyperparathyroidism | |Secondary hyperparathyroidism | ||
| | |||
| | | | ||
| | | | ||
Line 182: | Line 189: | ||
|- | |- | ||
|Hyperthyroidism | |Hyperthyroidism | ||
| | |||
| | | | ||
| | | | ||
Line 200: | Line 208: | ||
|- | |- | ||
|Hypothyroidism | |Hypothyroidism | ||
| | |||
| | | | ||
| | | | ||
Line 217: | Line 226: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Inflammatory / Rheumatologic | ||
|- | |- | ||
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | |Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
Line 223: | Line 232: | ||
* 40s-50s | * 40s-50s | ||
* Can affect childreen | * Can affect childreen | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
Line 253: | Line 263: | ||
| | | | ||
* > 18 years | * > 18 years | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
Line 274: | Line 285: | ||
| | | | ||
* 50s | * 50s | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| + | | + | ||
Line 293: | Line 305: | ||
| | | | ||
* 40-50s | * 40-50s | ||
| | |||
| | | | ||
+ | + | ||
Line 323: | Line 336: | ||
| | | | ||
* 50s | * 50s | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 346: | Line 360: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Genetic | ||
|- | |- | ||
|Becker muscular dystrophy | |Becker muscular dystrophy | ||
|<13yrs | |<13yrs | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 374: | Line 389: | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
|<13 yrs | |<13 yrs | ||
| | |||
| + | | + | ||
| - | | - | ||
Line 400: | Line 416: | ||
|Limb-girdle muscular dystrophies | |Limb-girdle muscular dystrophies | ||
|<15 yrs | |<15 yrs | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 429: | Line 446: | ||
|- | |- | ||
|Myotonic dystrophy type 1 | |Myotonic dystrophy type 1 | ||
| | |||
| | | | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 454: | Line 472: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Infectious | ||
|- | |- | ||
|Lyme disease | |Lyme disease | ||
|Variable | |Variable | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 488: | Line 507: | ||
|Infulenza | |Infulenza | ||
|Variable | |Variable | ||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 516: | Line 536: | ||
|Polio | |Polio | ||
|<5 yrs | |<5 yrs | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 546: | Line 567: | ||
|Syphilis | |Syphilis | ||
|Variable | |Variable | ||
| | |||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 579: | Line 601: | ||
|Pyomyositis | |Pyomyositis | ||
|Variable | |Variable | ||
| | |||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
Line 605: | Line 628: | ||
* - | * - | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Neurologic | ||
|- | |- | ||
|ALS | |ALS | ||
| | |||
| | | | ||
| | | | ||
Line 626: | Line 650: | ||
|- | |- | ||
|Stroke | |Stroke | ||
| | |||
| | | | ||
| | | | ||
Line 644: | Line 669: | ||
|- | |- | ||
|GBS | |GBS | ||
| | |||
| | | | ||
| | | | ||
Line 662: | Line 688: | ||
|- | |- | ||
|Multiple Sclerosis | |Multiple Sclerosis | ||
| | |||
| | | | ||
| | | | ||
Line 679: | Line 706: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Neuro-muscular | ||
|- | |- | ||
|Botulisim | |Botulisim | ||
| | |||
| | | | ||
| | | | ||
Line 700: | Line 728: | ||
|- | |- | ||
|Lambert-Eaton myaes | |Lambert-Eaton myaes | ||
| | |||
| | | | ||
| | | | ||
Line 718: | Line 747: | ||
|- | |- | ||
|Myasthenia gravis | |Myasthenia gravis | ||
| | |||
| | | | ||
| | | | ||
Line 735: | Line 765: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Paraneoplastic | ||
|- | |- | ||
| | |||
| | | | ||
| | | | ||
Line 755: | Line 786: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="18" |Metabolic | ||
|- | |- | ||
|Glycogen storage disease | |Glycogen storage disease | ||
| | |||
| | | | ||
| | | | ||
Line 776: | Line 808: | ||
|- | |- | ||
|Lipid storage disease | |Lipid storage disease | ||
| | |||
| | | | ||
| | | | ||
Line 794: | Line 827: | ||
|- | |- | ||
|Mitochondrial | |Mitochondrial | ||
| | |||
| | | | ||
| | | |
Revision as of 18:28, 3 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Differentiating Various Muscle Weakness
Disease | Symptoms | History | Physical
Examination |
Diagnosis | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Site of muscle weakness | Muscle weakness | Fever | Muscle pain | Gait abnormality | Neuropathy | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |||||
Proximal | DIstal | ||||||||||||||||
Medications | |||||||||||||||||
Corticosteroids | Variable | + | - | - | + | - | - | - |
|
|
|
|
- | - | - | ||
Statins | 60+ | + | - | - | + | - | - | -/+(rhabdomyolysis) |
|
|
|
|
|
|
- | ||
Alcohol | Variable | + | + |
|
|||||||||||||
Endocrine | |||||||||||||||||
Cushing's disease | 25 -45 | + | - | - | - | - | - | - |
|
|
|
- | - | - | |||
Adrenal insufficiency | - | ||||||||||||||||
Secondary hyperparathyroidism | |||||||||||||||||
Hyperthyroidism | |||||||||||||||||
Hypothyroidism | |||||||||||||||||
Inflammatory / Rheumatologic | |||||||||||||||||
Dermatomyositis[1] |
|
+ | - | + | + | - | - | - |
|
|
|
|
| ||||
Polymyositis[2] |
|
+ | - | + | + | - | - | - | - | - |
|
|
|||||
Inclusion body myositis[3] |
|
+ | + |
|
|||||||||||||
Fibomyalgia |
|
+ |
- | - | - | - | ++ | - |
|
|
|
|
|
|
| ||
Polymyalgia Rheumatica[4] |
|
+ | - | + | + | - | - | - |
|
|
|
|
|
|
| ||
Genetic | |||||||||||||||||
Becker muscular dystrophy | <13yrs | + | - | - | - | + | - | - |
|
|
|
|
| ||||
Duchenne muscular dystrophy | <13 yrs | + | - | - | - | + | - | - |
|
|
|
| |||||
Limb-girdle muscular dystrophies | <15 yrs | + | - | - | + | + | - | - |
|
|
|
|
|
|
|||
Myotonic dystrophy type 1 | + | + | - | - | + | - | - |
|
|||||||||
Infectious | |||||||||||||||||
Lyme disease | Variable | + | - | + | + | +/- | + | - |
|
|
|
|
|
|
| ||
Infulenza | Variable | - | - | + | + | + | - | + |
|
|
|
|
|
|
| ||
Polio | <5 yrs | + | - | - | - | + | + | - |
|
|
|
|
|
| |||
Syphilis | Variable | - | - | - | - | + | + | - |
|
|
|
|
|
|
| ||
Pyomyositis | Variable | +/- | +/- | + | + | - | - | - |
|
|
|
|
|
|
| ||
Neurologic | |||||||||||||||||
ALS | |||||||||||||||||
Stroke | |||||||||||||||||
GBS | |||||||||||||||||
Multiple Sclerosis | |||||||||||||||||
Neuro-muscular | |||||||||||||||||
Botulisim | |||||||||||||||||
Lambert-Eaton myaes | |||||||||||||||||
Myasthenia gravis | |||||||||||||||||
Paraneoplastic | |||||||||||||||||
Metabolic | |||||||||||||||||
Glycogen storage disease | |||||||||||||||||
Lipid storage disease | |||||||||||||||||
Mitochondrial |
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.